GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (MEX:GRF N) » Definitions » Common Stock

Grifols (MEX:GRF N) Common Stock : MXN2,611.96 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Grifols Common Stock?

Grifols's quarterly common stock increased from Jun. 2024 (MXN2,358.62 Mil) to Sep. 2024 (MXN2,613.81 Mil) but then declined from Sep. 2024 (MXN2,613.81 Mil) to Dec. 2024 (MXN2,611.96 Mil).

Grifols's annual common stock declined from Dec. 2022 (MXN2,470.13 Mil) to Dec. 2023 (MXN2,213.95 Mil) but then increased from Dec. 2023 (MXN2,213.95 Mil) to Dec. 2024 (MXN2,611.96 Mil).


Grifols Common Stock Historical Data

The historical data trend for Grifols's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Common Stock Chart

Grifols Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,894.36 2,772.38 2,470.13 2,213.95 2,611.96

Grifols Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,223.45 2,213.95 2,358.62 2,613.81 2,611.96

Grifols Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Grifols Business Description

Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Grifols Headlines

No Headlines